{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T23:31:19Z","timestamp":1671579079883},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.vaccine.2008.11.101","type":"journal-article","created":{"date-parts":[[2008,12,19]],"date-time":"2008-12-19T13:34:57Z","timestamp":1229693697000},"page":"1055-1061","source":"Crossref","is-referenced-by-count":4,"title":["Differential immunogenicity of Vibrio cholerae O139 variants expressing different combinations of naturally occurring and atypical forms of the serogroup polysaccharide"],"prefix":"10.1016","volume":"27","author":[{"given":"S.R.","family":"Attridge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Wallerstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.-L.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Morona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Holmgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.11.101_bib1","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3201\/eid0909.020443","article-title":"Reemergence of epidemic Vibrio cholerae O139, Bangladesh","volume":"9","author":"Faruque","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2008.11.101_bib2","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1128\/JCM.40.7.2635-2637.2002","article-title":"Escalating association of Vibrio cholerae O139 with cholera outbreaks in India","volume":"40","author":"Sinha","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.101_bib3","first-page":"261","article-title":"Cholera, 2004","volume":"80","author":"World Health Organization","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2008.11.101_bib4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up","volume":"i","author":"Clemens","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.11.101_bib5","series-title":"New generation vaccines","first-page":"499","article-title":"Oral B-subunit killed whole-cell cholera vaccine","author":"Holmgren","year":"2004"},{"key":"10.1016\/j.vaccine.2008.11.101_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1286-4579(03)00035-2","article-title":"Vibrio cholerae O139 Bengal: odyssey of a fortuitous variant","volume":"5","author":"Ramamurthy","year":"2003","journal-title":"Microb Infect"},{"key":"10.1016\/j.vaccine.2008.11.101_bib7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","article-title":"Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults","volume":"25","author":"Anh","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.101_bib8","first-page":"2","article-title":"Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam","volume":"80","author":"Trach","year":"2002","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2008.11.101_bib9","series-title":"Vibrio cholerae and cholera. Molecular to global perspectives","first-page":"77","article-title":"Molecular basis for O-antigen biosynthesis in Vibrio cholerae O1: Ogawa-Inaba switching","author":"Manning","year":"1994"},{"key":"10.1016\/j.vaccine.2008.11.101_bib10","doi-asserted-by":"crossref","first-page":"11388","DOI":"10.1073\/pnas.91.24.11388","article-title":"The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants","volume":"91","author":"Waldor","year":"1994","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2008.11.101_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/mpat.2000.0426","article-title":"Isolation and characterization of bacteriophage-resistant mutants of Vibrio cholerae O139","volume":"30","author":"Attridge","year":"2001","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2008.11.101_bib12","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1128\/jb.174.16.5228-5236.1992","article-title":"Nucleotide sequences of the genes regulating O-polysaccharide antigen chain length (rol) from Escherichia coli and Salmonella typhimurium: protein homology and functional complementation","volume":"174","author":"Batchelor","year":"1992","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2008.11.101_bib13","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1099\/mic.0.26141-0","article-title":"Genetic modulation of Shigella flexneri 2a lipopolysaccharide O antigen modal chain length reveals that it has been optimized for virulence","volume":"149","author":"Morona","year":"2003","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2008.11.101_bib14","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1128\/JB.188.7.2735-2739.2006","article-title":"Altering the length of the lipopolysaccharide O antigen has an impact on the interaction of Salmonella enterica serovar Typhimurium with macrophages and complement","volume":"188","author":"Murray","year":"2006","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2008.11.101_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2958.1999.01591.x","article-title":"Analysis of Shigella flexneri Wzz (Rol) function by mutagenesis and cross-linking: Wzz is able to oligomerise","volume":"34","author":"Daniels","year":"1999","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.101_bib16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2958.1997.3731744.x","article-title":"Effect of mutations in Shigella flexneri chromosomal and plasmid-encoded lipopolysaccharide genes on invasion and serum resistance","volume":"24","author":"Hong","year":"1997","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.101_bib17","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1365-2958.2003.03383.x","article-title":"Regulation of Salmonella typhimurium lipopolysaccharide O antigen chain length is required for virulence; identification of FepE as a second Wzz","volume":"47","author":"Murray","year":"2003","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.101_bib18","first-page":"383","article-title":"A sensitive microplate assay for the detection of bactericidal antibodies to Vibrio cholerae O139","volume":"9","author":"Attridge","year":"2002","journal-title":"Clin Diag Lab Immunol"},{"key":"10.1016\/j.vaccine.2008.11.101_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nsmb0208-121","article-title":"Stop and go: regulation of chain length in the biosynthesis of bacterial polysaccharides","volume":"15","author":"Whitfield","year":"2008","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2008.11.101_bib20","series-title":"Vibrio cholerae and cholera. Molecular to global perspectives","first-page":"395","article-title":"Recombinant live cholera vaccines","author":"Levine","year":"1994"},{"key":"10.1016\/j.vaccine.2008.11.101_bib21","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1086\/421275","article-title":"Incomplete correlation of serum vibriocidal antibody titre with protection from Vibrio cholerae infection in urban Bangladesh","volume":"189","author":"Saha","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.11.101_bib22","doi-asserted-by":"crossref","first-page":"6784","DOI":"10.1016\/j.vaccine.2008.10.011","article-title":"Murine antibody responses following systemic or mucosal immunization with viable or inactivated Vibrio cholerae","volume":"26","author":"Nygren","year":"2008","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08016757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08016757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T13:23:25Z","timestamp":1545571405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08016757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0264410X08016757"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.101","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}